Hypertension
Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure | BioSpace
Source Node: 3081002
Time Stamp: Jan 22, 2024
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2023 Global Net Product Revenues and Provides Additional Updates
Source Node: 3050900
Time Stamp: Jan 7, 2024
Nanowear Announces FDA 510(k) Clearance for AI-enabled Continuous Blood Pressure Monitoring and Hypertension Diagnostic Management: SimpleSense-BP
Source Node: 3049498
Time Stamp: Jan 5, 2024
Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval | BioSpace
Source Node: 3043191
Time Stamp: Jan 1, 2024
Development of Prediction Model for Brain Amyloid-Beta Accumulation Using Wristband Sensor
Source Node: 3039769
Time Stamp: Dec 29, 2023
Strategies for non-viral vectors targeting organs beyond the liver – Nature Nanotechnology
Source Node: 3038377
Time Stamp: Dec 27, 2023
Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors | BioSpace
Source Node: 3038279
Time Stamp: Dec 26, 2023
5 Interesting Startup Deals You May Have Missed This Year
Source Node: 3032838
Time Stamp: Dec 20, 2023
In a more sustainable and secure food system, dairy has a place at the table | GreenBiz
Source Node: 2983409
Time Stamp: Nov 28, 2023
BD Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results | BioSpace
Source Node: 2969923
Time Stamp: Nov 8, 2023
Meet five medical companies that have received 2023 business awards from the Institute of Physics – Physics World
Source Node: 2963173
Time Stamp: Oct 30, 2023
Positive six-month follow-up results for Recor’s renal denervation system
Source Node: 2959624
Time Stamp: Oct 27, 2023
Cannabis consumers who caught COVID had ‘better outcomes and mortality’ than non-consumers, study finds
Source Node: 2934304
Time Stamp: Oct 14, 2023
Intarcia’s Diabetes Drug-Device Implant Unanimously Rejected by Adcomm | BioSpace
Source Node: 2893876
Time Stamp: Sep 21, 2023
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients | BioSpace
Source Node: 2889216
Time Stamp: Sep 18, 2023
AI Infused Software as a Medical Device (SaMD) for Ischemic Stroke Detection Approved in China
Source Node: 2881790
Time Stamp: Sep 14, 2023